Title : Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Pub. Date : 2012 Jul 17

PMID : 22700809






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Prior to IFN-beta treatment, each 10 nmol/L increase in 25-hydroxyvitamin D was associated with 12.7% (p = 0.037) reduced odds for new T1 gadolinium-enhancing lesions, 11.7% (p = 0.044) for new T2 lesions, and 14.1% (p = 0.024) for combined unique activity. 25-hydroxyvitamin D interferon beta 1 Homo sapiens